Earningsreport

Q2/2024 12/31/2023 EPS -0.030 ZacksConsensus -0.030 ActVsEst 0.000 - In-Line

InnovAge Holding Corp.  (INNV) 
NASDAQ:AMEX Investor Relations: innovuspharma.com